Oramed Pharmaceuticals

ORMP

Börsenwert 161 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	SM 1 Sabby Management Miami Beach, Florida	2,48 Mio. $	-832.127 $	-251.550	-27 %
2	2 Renaissance Technologies New York	382.000 $	+153.911 $	+46.527	+79 %
3	3 BlackRock New York	261.000 $	+8.353 $	+2.525	+4 %
4	4 Barclays London, United Kingdom	150.000 $	–	–	–
5	5 Morgan Stanley New York	97.000 $	-5.600 $	-1.693	-6 %
6	6 DAFNA Capital Management Los Angeles, California	95.000 $	+33.080 $	+10.000	+63 %
7	7 PNC Financial Services Group Pittsburgh, Pennsylvania	77.000 $	–	–	–
8	8 Glenmede Trust Philadelphia, Pennsylvania	72.000 $	–	–	–
9	9 Rossmore Private Capital Glastonbury, Connecticut	55.000 $	–	–	–
10	10 Panagora Asset Management Boston, Massachusetts	47.000 $	+12.256 $	+3.705	+40 %
11	11 Deutsche Bank Frankfurt Am Main Ge, Germany	38.000 $	+34.823 $	+10.527	Neu
12	12 Wells Fargo San Francisco, California	37.000 $	–	–	–
13	13 Citigroup New York	35.000 $	–	–	–
14	14 Close Asset Management London, United Kingdom	27.000 $	+24.148 $	+7.300	+3.650 %
15	15 Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania	11.000 $	–	–	–
16	16 Bank of Montreal Toronto, Ontario, Canada	6.000 $	–	–	–
17	17 Royal Bank of Canada Toronto, Ontario, Canada	6.000 $	–	–	–
18	18 UBS Group Zurich, Switzerland	5.000 $	-5.184 $	-1.567	-56 %
19	19 SeaCrest Wealth Management Purchase, New York	5.000 $	+4.962 $	+1.500	Neu
20	20 Tower Research Capital (TRC) New York	5.000 $	+4.982 $	+1.506	Neu
21	21 Advisor Group Phoenix, Arizona	4.000 $	–	–	–
22	22 Bank of America Charlotte, North Carolina	4.000 $	–	–	–
23	23 JFS Wealth Advisors Hermitage, Pennsylvania	2.000 $	–	–	–
24	24 Ladenburg Thalmann Financial Services Miami, Florida	2.000 $	–	–	–
25	25 Nordea Investment Management Stockholm, Sweden	2.000 $	–	–	–

Oramed Pharmaceuticals ORMP Börsenwert 161 Mio. $

Oramed Pharmaceuticals

ORMP

Börsenwert 161 Mio. $